{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 448141514
| IUPAC_name = 2-(3,4-dichlorophenyl)- N-methyl- N-[(5R,7S,8S)- 7-pyrrolidin-1-yl- 1-oxaspiro[4.5]decan-8-yl] acetamide
| image = Spiradoline.png
| width = 200

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration = N/A

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 87151-85-7
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 55652
| IUPHAR_ligand = 1653
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 118865
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = N18ZH0M4NP
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID      = 50257

<!--Chemical data-->
| C=22 | H=30 | Cl=2 | N=2 | O=2 
| molecular_weight = 425.392 g/mol
| smiles = CN([C@H]1CC[C@@]2(CCCO2)C[C@@H]1N3CCCC3)C(=O)CC4=CC(=C(C=C4)Cl)Cl
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI          = 1S/C22H30Cl2N2O2/c1-25(21(27)14-16-5-6-17(23)18(24)13-16)19-7-9-22(8-4-12-28-22)15-20(19)26-10-2-3-11-26/h5-6,13,19-20H,2-4,7-12,14-15H2,1H3/t19-,20-,22-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey       = NYKCGQQJNVPOLU-ONTIZHBOSA-N
}}

'''Spiradoline''' ('''U-62066''') is a drug which acts as a highly selective [[kappa opioid receptor|κ-opioid]] [[agonist]].<ref>Vonvoigtlander PF, Lewis RA. Analgesic and mechanistic evaluation of spiradoline, a potent kappa opioid. ''Journal of Pharmacology and Experimental Therapeutics''. 1988 Jul;246(1):259-62. {{PMID|2839665}}</ref> It has [[analgesic]],<ref>Kunihara M, Ohyama M, Nakano M, Hayashi S. Analgesic activity of spiradoline mesylate (U-62,066E), a kappa opioid agonist in mice. ''Life Sciences''. 1989;45(13):1191-8. {{PMID|2796604}}</ref> [[diuretic]]<ref>Yamada K, Imai M, Yoshida S. Mechanism of diuretic action of U-62,066E, a kappa opioid receptor agonist. ''European Journal of Pharmacology''. 1989 Jan 31;160(2):229-37. {{DOI|10.1016/0014-2999(89)90495-0}} {{PMID|2547626}}</ref> and [[antitussive]] effects,<ref>Kamei J, Tanihara H, Kasuya Y. Antitussive effects of two specific kappa-opioid agonists, U-50,488H and U-62,066E, in rats. ''European Journal of Pharmacology''. 1990 Oct 9;187(2):281-6. {{PMID|2272363}}</ref> and produces subjective effects in animals similar to those of [[ketazocine]] and [[alazocine]].<ref>Holtzman SG. Further characterization of the discriminative stimulus effects of spiradoline. ''Pharmacology, Biochemistry and Behaviour''. 2000 Jul;66(3):517-22. {{PMID|10899364}}</ref> The main effect in humans is [[sedation]], along with analgesic and diuretic effects, but significant side effects such as [[dysphoria]] and [[hallucinations]] have stopped it from being used clinically.<ref>Wadenberg ML. A review of the properties of spiradoline: a potent and selective kappa-opioid receptor agonist. ''CNS Drug Reviews''. 2003 Summer;9(2):187-98. {{PMID|12847558}}</ref> Kappa-agonists have been shown to react negatively with the [[m-opioid receptor|mu receptor]]{{Citation needed|reason=Source??|date=March 2014}}, instead of having an assumed synergy since they are both [[opioid receptors]],  such as with the [[m-opioid receptor|mu (μ) receptors]] and [[Δ-opioid receptor|delta (δ) receptors]] (which both mediate pain-relief, euphoria and overall potency of opioid effects).

==See also==
* [[Enadoline]]

==References==
{{Reflist|2}}

{{Hallucinogens}}
{{Opioidergics}}

[[Category:Dissociative drugs]]
[[Category:Chloroarenes]]
[[Category:Acetamides]]
[[Category:Pyrrolidines]]
[[Category:Kappa agonists]]


{{hallucinogen-stub}}